Symbols

Symbols

VTYX

VTYX

Ventyx Biosciences' VTX3232 Fails to Meet Weight Loss Expectations in Phase 2 Trial

Ventyx Biosciences: MACD Death Cross, Bollinger Bands Narrowing on 15min Chart.

Ventyx Biosciences's 15min chart sees MACD Death Cross, KDJ Death Cross

Friday Nov 07, 2025

Ventyx Biosciences: Buy rating maintained with PT raised to $16.

Wells Fargo Boosts Ventyx Biosciences PT to $14 from $11, Keeps Overweight Rating

Wednesday Nov 05, 2025

Ventyx Biosciences shares rise 12.97% intraday after H.C. Wainwright upgrades to Buy with $18 price target.

Ventyx Biosciences upgraded by HC Wainwright to Buy, PT $18.

Tuesday Nov 04, 2025

Ventyx Biosciences' 15min Chart Indicates Bollinger Bands Expanding Upward, KDJ Golden Cross

Thursday Oct 30, 2025

Ventyx Biosciences (VTYX) up more than 100% since Oct 22

Wednesday Oct 29, 2025

Ventyx Biosciences: Bollinger Bands Narrowing, KDJ Death Cross on 15min Chart

Tuesday Oct 28, 2025

Ventyx Biosciences's 15min chart exhibits MACD Death Cross, KDJ Death Cross signals.

Ventyx Biosciences's 15-min chart shows RSI overbought, narrowing Bollinger Bands.

Monday Oct 27, 2025

Ventyx Biosciences Valuation After Breakthrough Phase 2 Results: Underpriced or Overhyped?

Ventyx Biosciences: Oppenheimer maintains Outperform, PT raised to $14 from $9.

Thursday Oct 23, 2025

Ventyx Biosciences: Bollinger Bands Narrowing, KDJ Death Cross on 15-Min Chart

Ventyx Biosciences Surges 90% as Company Reports Data Win in CV, Market Cap Valuation Tops $500M

Pre-Market Most Active Stocks for Oct 23, 2025: BYND, VTYX, IONZ, TSLL, QBTS, RGTZ, IONQ, TNGX, NOK, QS, NIO, BBAI

Ventyx Biosciences (VTYX) up more than 100% since Sep 26

VTYX Surges 83% After Positive Phase 2 Data for VTX3232.

Ventyx Shares Soar 86.5% After Hours on Positive Phase 2 Trial Results for Obesity Drug Candidate